All public logs

Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

Logs

All public logs Block log Content model change log Deletion log Import log Merge log Move log Patrol log Protection log Semantic MediaWiki log Tag log Tag management log Upload log User creation log User merge log User rights log Performer:  Target (title or User:username for user):   Search titles starting with this text

From year (and earlier): From month (and earlier): all January February March April May June July August September October November December

Tag filter: 

Show patrol log | Show tag log | Show Semantic MediaWiki log

(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)

• 18:15, 13 October 2019 Jwarner (talk | contribs) uploaded a new version of File:Bishal gyawali.jpg
• 18:13, 13 October 2019 Jwarner (talk | contribs) uploaded File:Bishal gyawali.jpg
• 15:48, 2 October 2019 Jwarner (talk | contribs) uploaded File:Eric Marks Headshot.jpg
• 10:13, 1 October 2019 Jwarner (talk | contribs) moved page Category:Autoimmune hemolytic anemia regimens to Category:Warm autoimmune hemolytic anemia regimens
• 10:04, 1 October 2019 Jwarner (talk | contribs) moved page Autoimmune hemolytic anemia to Warm autoimmune hemolytic anemia (More accurate)
• 16:27, 6 September 2019 Jwarner (talk | contribs) moved page Nintedanib (BIBF 1120) to Nintedanib (Vargatef)
• 11:50, 19 August 2019 Jwarner (talk | contribs) moved page Entrectinib (RXDX-101) to Entrectinib (Rozlytrek) (FDA approval)
• 10:20, 6 August 2019 Jwarner (talk | contribs) moved page Lobaplatin to Lobaplatin (D-19466)
• 13:45, 5 August 2019 Jwarner (talk | contribs) moved page Epratuzumab (humanised anti-CD22 antibody) to Epratuzumab (LymphoCide) (brand name available)
• 13:01, 31 July 2019 Jwarner (talk | contribs) moved page Darolutamide (ODM-201) to Darolutamide (Nubeqa) (FDA approval)
• 14:12, 3 July 2019 Jwarner (talk | contribs) moved page Selinexor (KPT-330) to Selinexor (Xpovio) (FDA approval)
• 19:25, 23 June 2019 Jwarner (talk | contribs) uploaded File:NShah.png
• 21:58, 19 June 2019 Jwarner (talk | contribs) moved page AZD5363 to Capivasertib (AZD5363)
• 13:31, 27 February 2019 Jwarner (talk | contribs) uploaded File:Social-twitter-icon.png (Twitter icon)
• 16:20, 7 February 2019 Jwarner (talk | contribs) moved page Heparin to Unfractionated heparin (UFH) (Concept refinement)
• 15:17, 6 February 2019 Jwarner (talk | contribs) moved page Caplacizumab (ALX-0081) to Caplacizumab (Cablivi) (FDA approval)
• 13:48, 9 January 2019 Jwarner (talk | contribs) uploaded File:Chowdhery.jpg (Rozina Chowdhery MD)
• 11:50, 9 January 2019 Jwarner (talk | contribs) uploaded File:Seifter.jpg (Ari Seifter MD)
• 10:35, 9 January 2019 Jwarner (talk | contribs) uploaded File:C Schwartz.jpg (Candice Schwartz MD)
• 15:05, 18 December 2018 Jwarner (talk | contribs) moved page SL-401 to Tagraxofusp (Elzonris) (Generic name available)
• 15:02, 18 December 2018 Jwarner (talk | contribs) moved page SGN-CD19A to Denintuzumab mafodotin (SGN-CD19A) (Generic name available)
• 14:57, 18 December 2018 Jwarner (talk | contribs) moved page CC-292 (AVL-292) to Spebrutinib (CC-292) (Generic name available)
• 14:49, 29 November 2018 Jwarner (talk | contribs) moved page Gilteritinib (ASP2215) to Gilteritinib (Xospata) (FDA approval)
• 23:20, 26 November 2018 Jwarner (talk | contribs) moved page Larotrectinib (LOXO-101) to Larotrectinib (Vitrakvi) (FDA approval)
• 22:26, 4 November 2018 Jwarner (talk | contribs) moved page Lorlatinib (PF-06463922) to Lorlatinib (Lorbrena) (FDA approval)
• 20:18, 1 November 2018 Jwarner (talk | contribs) uploaded File:Release notes 2018-10-29.docx
• 12:41, 10 October 2018 Jwarner (talk | contribs) moved page Uterine cancer to Endometrial cancer (More common naming convention)
• 22:38, 9 October 2018 Jwarner (talk | contribs) moved page Category:Nonsteroidal androgen receptor inhibitors to Category:Nonsteroidal antiandrogens
• 15:25, 4 October 2018 Jwarner (talk | contribs) moved page Emicizumab-kxwh (Hemlibra) to Emicizumab (Hemlibra)
• 11:39, 2 October 2018 Jwarner (talk | contribs) moved page Cemiplimab (REGN2810) to Cemiplimab (Libtayo) (FDA approval)
• 19:34, 27 September 2018 Jwarner (talk | contribs) moved page Dacomitinib (PF-00299804) to Dacomitinib (Vizimpro) (FDA approval)
• 21:25, 26 September 2018 Jwarner (talk | contribs) moved page Duvelisib (IPI-145) to Duvelisib (Copiktra) (FDA approval)
• 15:13, 13 September 2018 Jwarner (talk | contribs) moved page Moxetumomab pasudotox (HA22) to Moxetumomab pasudotox (Lumoxiti) (FDA approval)
• 13:19, 7 September 2018 Jwarner (talk | contribs) uploaded File:Release notes 2018-08-25.docx (Ontology version 2018-08-25 release notes)
• 16:39, 28 August 2018 Jwarner (talk | contribs) uploaded File:Release notes 2018-08-17.docx (Ontology version 2018-08-17 release notes)
• 08:02, 23 August 2018 Jwarner (talk | contribs) moved page Von Willebrand Factor and factor VIII complex, human to Von Willebrand factor and factor VIII complex, human (Naming convention)
• 22:27, 11 August 2018 Jwarner (talk | contribs) moved page Mepolizumab (Bosatria) to Mepolizumab (Nucala) (FDA approval under a different brand name)
• 13:54, 10 August 2018 Jwarner (talk | contribs) moved page Mogamulizumab (KW-0761) to Mogamulizumab (Poteligeo) (FDA approval)
• 14:29, 7 August 2018 Jwarner (talk | contribs) moved page Basal cell carcinoma (BCC) to Cutaneous basal cell carcinoma
• 14:24, 7 August 2018 Jwarner (talk | contribs) moved page Squamous cell carcinoma (SCC) to Cutaneous squamous cell carcinoma
• 13:50, 30 July 2018 Jwarner (talk | contribs) moved page Epinephrine (Epipen) to Epinephrine autoinjector (Epipen)
• 18:17, 20 July 2018 Jwarner (talk | contribs) moved page Ivosidenib (AG-120) to Ivosidenib (Tibsovo) (FDA approval)
• 18:04, 20 July 2018 Jwarner (talk | contribs) moved page Ticlodipine (Ticlid) to Ticlopidine (Ticlid) (typo)
• 19:50, 27 June 2018 Jwarner (talk | contribs) moved page Binimetinib (MEK162) to Binimetinib (Mektovi) (FDA approval)
• 19:45, 27 June 2018 Jwarner (talk | contribs) moved page Encorafenib (LGX818) to Encorafenib (Braftovi) (FDA approval)
• 22:57, 6 June 2018 Jwarner (talk | contribs) moved page Test: Jane Doe to Academic Medicine wiki-based narrative
• 21:09, 23 May 2018 Jwarner (talk | contribs) uploaded File:Release notes 2018-05-08.docx (HemOnc.org ontology version 2018-05-08 release notes.)
• 14:38, 21 May 2018 Jwarner (talk | contribs) moved page Avatrombopag (E5501) to Avatrombopag (Doptelet) (FDA approval)
• 14:36, 11 May 2018 Jwarner (talk | contribs) moved page AG-120 to Ivosidenib (AG-120) (generic name available)
• 13:51, 4 May 2018 Jwarner (talk | contribs) moved page Andexanet alfa (PRT4445) to Factor Xa, recombinant, inactivated-zhzo (Andexxa) (FDA approval)

(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)